These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

489 related items for PubMed ID: 18602677

  • 1. Combination chemotherapy with carboplatin, paclitaxel and pegylated liposomal doxorubicin for advanced or recurrent carcinosarcoma of the uterus: clinical experience of a single institution.
    Pectasides D, Pectasides E, Papaxoinis G, Xiros N, Sykiotis C, Papachristodoulou A, Tountas N, Panayiotides J, Economopoulos T.
    Gynecol Oncol; 2008 Sep; 110(3):299-303. PubMed ID: 18602677
    [Abstract] [Full Text] [Related]

  • 2. Carboplatin and paclitaxel in advanced or metastatic endometrial cancer.
    Pectasides D, Xiros N, Papaxoinis G, Pectasides E, Sykiotis C, Koumarianou A, Psyrri A, Gaglia A, Kassanos D, Gouveris P, Panayiotidis J, Fountzilas G, Economopoulos T.
    Gynecol Oncol; 2008 May; 109(2):250-4. PubMed ID: 18299146
    [Abstract] [Full Text] [Related]

  • 3. A multicentre phase II study of carboplatin plus pegylated liposomal doxorubicin as first-line chemotherapy for patients with advanced or recurrent endometrial carcinoma: the END-1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) group.
    Pignata S, Scambia G, Pisano C, Breda E, Di Maio M, Greggi S, Ferrandina G, Lorusso D, Zagonel V, Febbraro A, Riva N, De Rosa V, Gallo C, Perrone F, Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies Group.
    Br J Cancer; 2007 Jun 04; 96(11):1639-43. PubMed ID: 17486128
    [Abstract] [Full Text] [Related]

  • 4. Paclitaxel and carboplatin with amifostine in advanced, recurrent, or refractory endometrial adenocarcinoma: a phase II study of the Southwest Oncology Group.
    Scudder SA, Liu PY, Wilczynski SP, Smith HO, Jiang C, Hallum AV, Smith GB, Hannigan EV, Markman M, Alberts DS, Southwest Oncology Group.
    Gynecol Oncol; 2005 Mar 04; 96(3):610-5. PubMed ID: 15721401
    [Abstract] [Full Text] [Related]

  • 5. Clinical experience with combination paclitaxel and carboplatin therapy for advanced or recurrent carcinosarcoma of the uterus.
    Toyoshima M, Akahira J, Matsunaga G, Niikura H, Ito K, Yaegashi N, Tase T.
    Gynecol Oncol; 2004 Sep 04; 94(3):774-8. PubMed ID: 15350372
    [Abstract] [Full Text] [Related]

  • 6. Paclitaxel, carboplatin and pegylated liposomal doxorubicin in ovarian and peritoneal carcinoma: a phase I study of the Gynecologic Oncology Group.
    Rose PG, Greer BE, Horowitz IR, Markman M, Fusco N.
    Gynecol Oncol; 2007 Jan 04; 104(1):114-9. PubMed ID: 16959305
    [Abstract] [Full Text] [Related]

  • 7. Combination therapy with pegylated liposomal doxorubicin and carboplatin in gynecologic malignancies: a prospective phase II study of the Arbeitsgemeinschaft Gynäekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and Kommission Uterus (AGO-K-Ut).
    du Bois A, Pfisterer J, Burchardi N, Loibl S, Huober J, Wimberger P, Burges A, Stähle A, Jackisch C, Kölbl H, Arbeitsgemeinschaft Gynäekologische Onkologie Studiengruppe Ovarialkarzinom, Kommission Uterus.
    Gynecol Oncol; 2007 Dec 04; 107(3):518-25. PubMed ID: 17910981
    [Abstract] [Full Text] [Related]

  • 8. Pegylated liposomal Doxorubicin and Carboplatin compared with Paclitaxel and Carboplatin for patients with platinum-sensitive ovarian cancer in late relapse.
    Pujade-Lauraine E, Wagner U, Aavall-Lundqvist E, Gebski V, Heywood M, Vasey PA, Volgger B, Vergote I, Pignata S, Ferrero A, Sehouli J, Lortholary A, Kristensen G, Jackisch C, Joly F, Brown C, Le Fur N, du Bois A.
    J Clin Oncol; 2010 Jul 10; 28(20):3323-9. PubMed ID: 20498395
    [Abstract] [Full Text] [Related]

  • 9. Carboplatin and paclitaxel for advanced and recurrent cervical carcinoma: the British Columbia Cancer Agency experience.
    Tinker AV, Bhagat K, Swenerton KD, Hoskins PJ.
    Gynecol Oncol; 2005 Jul 10; 98(1):54-8. PubMed ID: 15904950
    [Abstract] [Full Text] [Related]

  • 10. Results of reinduction therapy with paclitaxel and carboplatin in recurrent epithelial ovarian cancer.
    Gronlund B, Høgdall C, Hansen HH, Engelholm SA.
    Gynecol Oncol; 2001 Oct 10; 83(1):128-34. PubMed ID: 11585424
    [Abstract] [Full Text] [Related]

  • 11. Association of pegylated liposomal doxorubicin and ifosfamide in early recurrent ovarian cancer patients: a multicenter phase II trial.
    Joly F, Sevin E, Lortholary A, Priou F, Paitel JF, Fabbro M, Henry-Amar M, Hamond K, Bourgeois H.
    Gynecol Oncol; 2010 Mar 10; 116(3):312-6. PubMed ID: 19887304
    [Abstract] [Full Text] [Related]

  • 12. Iniparib plus paclitaxel and carboplatin as initial treatment of advanced or recurrent uterine carcinosarcoma: a Gynecologic Oncology Group Study.
    Aghajanian C, Sill MW, Secord AA, Powell MA, Steinhoff M.
    Gynecol Oncol; 2012 Sep 10; 126(3):424-7. PubMed ID: 22634397
    [Abstract] [Full Text] [Related]

  • 13. Phase II study of paclitaxel in combination with carboplatin for patients with recurrent or persistent uterine sarcoma.
    Yoo HJ, Lim MC, Lim S, Park JY, Kang S, Park SY, Seo SS.
    Arch Gynecol Obstet; 2012 Dec 10; 286(6):1529-35. PubMed ID: 22825691
    [Abstract] [Full Text] [Related]

  • 14. Pegylated liposomal doxorubicin in combination with vinorelbine as salvage treatment in pretreated patients with advanced breast cancer: a multicentre phase II study.
    Ardavanis A, Mavroudis D, Kalbakis K, Malamos N, Syrigos K, Vamvakas L, Kotsakis A, Kentepozidis N, Kouroussis C, Agelaki S, Georgoulias V, Breast Cancer Committee of the Hellenic Oncology Research Group.
    Cancer Chemother Pharmacol; 2006 Dec 10; 58(6):742-8. PubMed ID: 16718470
    [Abstract] [Full Text] [Related]

  • 15. Paclitaxel and pegylated liposomal doxorubicin in recurrent head and neck cancer: clinical and unexpected pharmacokinetic interactions.
    Airoldi M, Cattel L, Milla P, Pedani F, Garzaro M, Dosio F.
    Anticancer Res; 2008 Dec 10; 28(4C):2519-27. PubMed ID: 18751444
    [Abstract] [Full Text] [Related]

  • 16. Pegylated liposomal doxorubicin and carboplatin in late-relapsing ovarian cancer: a GINECO group phase II trial.
    Weber B, Lortholary A, Mayer F, Bourgeois H, Orfeuvre H, Combe M, Platini C, Cretin J, Fric D, Paraiso D, Pujade-Lauraine E.
    Anticancer Res; 2009 Oct 10; 29(10):4195-200. PubMed ID: 19846972
    [Abstract] [Full Text] [Related]

  • 17. Biweekly pegylated liposomal doxorubicin as second-line treatment in patients with relapsed ovarian cancer after failure of platinum and paclitaxel: results from a multi-center phase II study of the NOGGO.
    Oskay-Oezcelik G, Koensgen D, Hindenburg HJ, Klare P, Schmalfeldt B, Lichtenegger W, Chekerov R, Al-Batran SE, Neumann U, Sehouli J, Ovarian Cancer Study Group of the North-Eastern Germany Society of Gynecological Oncology (NOGGO).
    Anticancer Res; 2008 Oct 10; 28(2B):1329-34. PubMed ID: 18505074
    [Abstract] [Full Text] [Related]

  • 18. Pegylated liposomal doxorubicin consolidation therapy after platinum/paclitaxel-based chemotherapy for suboptimally debulked, advanced-stage epithelial ovarian cancer patients.
    Rocconi RP, Straughn JM, Leath CA, Kilgore LC, Huh WK, Barnes MN, Partridge EE, Alvarez RD.
    Oncologist; 2006 Apr 10; 11(4):336-41. PubMed ID: 16614229
    [Abstract] [Full Text] [Related]

  • 19. Carboplatin plus paclitaxel versus carboplatin plus pegylated liposomal doxorubicin as first-line treatment for patients with ovarian cancer: the MITO-2 randomized phase III trial.
    Pignata S, Scambia G, Ferrandina G, Savarese A, Sorio R, Breda E, Gebbia V, Musso P, Frigerio L, Del Medico P, Lombardi AV, Febbraro A, Scollo P, Ferro A, Tamberi S, Brandes A, Ravaioli A, Valerio MR, Aitini E, Natale D, Scaltriti L, Greggi S, Pisano C, Lorusso D, Salutari V, Legge F, Di Maio M, Morabito A, Gallo C, Perrone F.
    J Clin Oncol; 2011 Sep 20; 29(27):3628-35. PubMed ID: 21844495
    [Abstract] [Full Text] [Related]

  • 20. A phase I study of ifosfamide, paclitaxel, and carboplatin in advanced and recurrent cervical cancer.
    Downs LS, Judson PL, Argenta PA, Carson LF, Boente MP.
    Gynecol Oncol; 2004 Nov 20; 95(2):347-51. PubMed ID: 15491756
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.